awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26862716-15C309FC-628B-4E61-AB4F-3E90A5F27E83
Q26862716-15C309FC-628B-4E61-AB4F-3E90A5F27E83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26862716-15C309FC-628B-4E61-AB4F-3E90A5F27E83
MicroRNAs and triple negative breast cancer
P2860
Q26862716-15C309FC-628B-4E61-AB4F-3E90A5F27E83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26862716-15C309FC-628B-4E61-AB4F-3E90A5F27E83
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8d2eb2fa194cd6ea6498326eb22750cbe0fb4941
P2860
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).